SCHEMBL3671265

SCHEMBL3671265

CC1CC2(C)CCCC(N)(C1)C2.[CH2]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
SLC22A1 O15245 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
ESR1 P03372 1/20 0.38
ADRB3 P13945 1/20 0.38
ACHE P22303 1/20 0.38
OPRK1 P41145 1/20 0.38
MTOR P42345 1/20 0.38
HTT P42858 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27045013 0.78 GRIN1 (0.46) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL21298754 0.73
SCHEMBL18972626 0.69 ALDH1A1 (0.38) ALDH1A1
SCHEMBL25973603 0.69 LMNA (0.35) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL9951831 0.69 LMNA (0.36) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL7913292 0.68 LMNA (0.42) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL19221390 0.66 LMNA (0.33) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL19084050 0.65 ALDH1A1 (0.32) ALDH1A1
SCHEMBL24970382 0.64 GRIN1 (0.46) LMNAGRIN1GRIN2ASLC22A1GRIN2D
SCHEMBL18902409 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170806-A1 ASSAY METHODS FOR MEMANTINE Generics Ýuk¨Limited (GB) 2010-04-07 EP disclosed
WO-2009010806-A1 ASSAY METHODS FOR MEMANTINE GENERICS [UK] LIMITED (GB) 2009-01-22 WO disclosed
EP-1742624-A2 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY Sepracor, Inc. (US) 2007-01-17 EP disclosed
WO-2005079851-A2 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY SEPRACOR, INC. (US) 2005-09-01 WO disclosed